[144] KEWAUNEE SCIENTIFIC CORP /DE/ SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Kewaunee Scientific Corp. (ticker KEQU) reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services LLC with an indicated aggregate market value of $130,170.00 and an approximate sale date of 10/08/2025. The filing shows those 3,000 shares were acquired as a stock award on 06/30/2024 and were paid as compensation. The filer also discloses a prior sale of 3,000 shares on 07/24/2025 with gross proceeds of $175,778.00. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.

Positive

• Disclosure compliance: Form 144 filed with broker and sale details disclosed
• Acquisition transparency: Shares were acquired as a stock award on 06/30/2024
• Seller representation: Seller attests to no undisclosed material adverse information

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 sale notice for 3,000 shares acquired as compensation.

The filing documents a proposed Rule 144 sale of 3,000 common shares via a broker, specifying acquisition as a stock award dated 06/30/2024 and payment characterized as compensation. The form includes the mandated seller representation about absence of undisclosed material adverse information, which supports procedural compliance.

Risks and near-term items to watch include the actual execution on 10/08/2025 and any subsequent filings that could show additional insider sales or amendments; monitoring trading notices or additional Form 4/Form 144 submissions in the weeks around that date will confirm execution and volume impact.

Equity Markets Analyst

TL;DR: The disclosed sale size is limited relative to total shares outstanding.

The notice lists total shares outstanding as 2,865,694 and an intended sale of 3,000 shares, indicating the trade size is small in absolute terms. The filing also records a prior sale of 07/24/2025 for 3,000 shares with gross proceeds shown.

Investors may monitor daily volume near the planned sale date to observe execution and price impact; additional disclosures such as Form 4 or amended notices would clarify actual sale timing and proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	3000	130170.00	2865694	10/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2024	Stock Award	Issuer			3000	06/30/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Donald Gardner 2700 West Front Street Statesville NC 28677	Kewaunee Scientific	07/24/2025	3000	175778.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)